
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Noradrenaline (Norepinephrine) - Clinical Notes</title>
    <meta name="description" content="Comprehensive evidence-based guide to noradrenaline in septic shock: dosing tables, calculations, clinical evidence from SOAP II, VASST, and latest research.">
    <meta name="keywords" content="noradrenaline, norepinephrine, septic shock, vasopressor, SOAP II, VASST, surviving sepsis campaign, dosage calculations, critical care">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            padding: 20px;
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: rgba(255, 255, 255, 0.95);
            backdrop-filter: blur(10px);
            border-radius: 20px;
            box-shadow: 0 20px 40px rgba(0, 0, 0, 0.1);
            overflow: hidden;
        }

        header {
            background: linear-gradient(135deg, #2c3e50, #34495e);
            color: white;
            padding: 40px;
            text-align: center;
        }

        h1 {
            font-size: 3em;
            font-weight: 700;
            margin-bottom: 15px;
            text-shadow: 2px 2px 4px rgba(0, 0, 0, 0.3);
        }

        .subtitle {
            font-size: 1.3em;
            opacity: 0.9;
            margin-bottom: 20px;
        }

        .nav-buttons {
            display: flex;
            justify-content: center;
            gap: 15px;
            margin-top: 25px;
            flex-wrap: wrap;
        }

        .nav-btn {
            background: rgba(255, 255, 255, 0.2);
            color: white;
            padding: 12px 25px;
            border: none;
            border-radius: 25px;
            cursor: pointer;
            transition: all 0.3s ease;
            font-size: 1em;
            font-weight: 500;
            backdrop-filter: blur(5px);
        }

        .nav-btn:hover, .nav-btn.active {
            background: rgba(255, 255, 255, 0.3);
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2);
        }

        .content {
            padding: 40px;
        }

        .tab-content {
            display: none;
        }

        .tab-content.active {
            display: block;
        }

        /* Introduction Styles */
        .intro-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
            margin-bottom: 40px;
        }

        .intro-card {
            background: white;
            padding: 30px;
            border-radius: 15px;
            box-shadow: 0 10px 25px rgba(0, 0, 0, 0.1);
            border-left: 5px solid #3498db;
        }

        .intro-card h3 {
            color: #2c3e50;
            font-size: 1.5em;
            margin-bottom: 15px;
        }

        .intro-card p {
            color: #7f8c8d;
            margin-bottom: 15px;
        }

        .intro-card ul {
            color: #7f8c8d;
            margin-left: 20px;
        }

        /* Key Info Box */
        .key-info {
            background: linear-gradient(135deg, #ff6b6b, #ee5a24);
            color: white;
            padding: 25px;
            border-radius: 15px;
            margin: 30px 0;
            text-align: center;
            box-shadow: 0 10px 20px rgba(238, 90, 36, 0.3);
        }

        .key-info h3 {
            font-size: 1.6em;
            margin-bottom: 15px;
        }

        /* Dosage Tables */
        .strength-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(350px, 1fr));
            gap: 30px;
            margin: 30px 0;
        }

        .strength-card {
            background: white;
            border-radius: 15px;
            padding: 25px;
            box-shadow: 0 15px 30px rgba(0, 0, 0, 0.1);
            border: 3px solid;
            transition: transform 0.3s ease;
        }

        .strength-card:hover {
            transform: translateY(-5px);
        }

        .single { border-color: #3498db; }
        .double { border-color: #e74c3c; }
        .quadruple { border-color: #f39c12; }

        .strength-header {
            text-align: center;
            margin-bottom: 20px;
            padding: 15px;
            border-radius: 10px;
            color: white;
            font-weight: bold;
            font-size: 1.3em;
        }

        .single .strength-header { background: linear-gradient(135deg, #3498db, #2980b9); }
        .double .strength-header { background: linear-gradient(135deg, #e74c3c, #c0392b); }
        .quadruple .strength-header { background: linear-gradient(135deg, #f39c12, #e67e22); }

        .preparation {
            background: #f8f9fa;
            padding: 15px;
            border-radius: 10px;
            margin-bottom: 20px;
            border-left: 4px solid #27ae60;
        }

        .preparation h4 {
            color: #27ae60;
            margin-bottom: 10px;
            font-size: 1.1em;
        }

        .dosage-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 15px;
            font-size: 0.9em;
        }

        .dosage-table th,
        .dosage-table td {
            padding: 12px 8px;
            text-align: center;
            border: 1px solid #ddd;
        }

        .dosage-table th {
            background: linear-gradient(135deg, #34495e, #2c3e50);
            color: white;
            font-weight: bold;
            font-size: 0.85em;
        }

        .dosage-table tr:nth-child(even) {
            background-color: #f8f9fa;
        }

        .dosage-table tr:hover {
            background-color: #e3f2fd;
        }

        .low-dose { background-color: #e8f5e8 !important; }
        .medium-dose { background-color: #fff3cd !important; }
        .high-dose { background-color: #f8d7da !important; }

        .formula-box {
            background: #2d3436;
            color: #00b894;
            padding: 15px;
            border-radius: 10px;
            margin: 15px 0;
            font-family: 'Courier New', monospace;
            font-size: 1.1em;
            text-align: center;
            border: 2px solid #00b894;
        }

        /* Calculation Steps */
        .step-container {
            margin-bottom: 40px;
        }

        .step-card {
            background: white;
            border-radius: 15px;
            padding: 30px;
            margin-bottom: 30px;
            box-shadow: 0 15px 30px rgba(0, 0, 0, 0.1);
            border-left: 5px solid #3498db;
        }

        .step-header {
            display: flex;
            align-items: center;
            margin-bottom: 20px;
        }

        .step-number {
            background: linear-gradient(135deg, #3498db, #2980b9);
            color: white;
            width: 50px;
            height: 50px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            font-size: 1.5em;
            margin-right: 20px;
        }

        .step-title {
            font-size: 1.8em;
            color: #2c3e50;
            font-weight: 600;
        }

        .calculation-box {
            background: #f8f9fa;
            border: 2px solid #e9ecef;
            border-radius: 10px;
            padding: 20px;
            margin: 20px 0;
            font-family: 'Courier New', monospace;
        }

        /* Evidence Section */
        .evidence-section {
            background: #f8f9fa;
            padding: 30px;
            border-radius: 15px;
            margin: 30px 0;
        }

        .evidence-section h2 {
            color: #2c3e50;
            font-size: 2.2em;
            margin-bottom: 25px;
            text-align: center;
        }

        .trial-card {
            background: white;
            padding: 25px;
            border-radius: 10px;
            margin-bottom: 25px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1);
            border-left: 5px solid #3498db;
        }

        .trial-title {
            color: #2c3e50;
            font-size: 1.4em;
            font-weight: 600;
            margin-bottom: 10px;
        }

        .trial-year {
            background: #3498db;
            color: white;
            padding: 5px 12px;
            border-radius: 15px;
            font-size: 0.9em;
            display: inline-block;
            margin-bottom: 15px;
        }

        /* Timeline */
        .timeline {
            position: relative;
            max-width: 1000px;
            margin: 40px auto;
        }

        .timeline::after {
            content: '';
            position: absolute;
            width: 6px;
            background-color: #3498db;
            top: 0;
            bottom: 0;
            left: 50%;
            margin-left: -3px;
        }

        .timeline-item {
            padding: 10px 40px;
            position: relative;
            background-color: inherit;
            width: 50%;
        }

        .timeline-item::after {
            content: '';
            position: absolute;
            width: 25px;
            height: 25px;
            right: -17px;
            background-color: white;
            border: 4px solid #3498db;
            top: 15px;
            border-radius: 50%;
            z-index: 1;
        }

        .left {
            left: 0;
        }

        .right {
            left: 50%;
        }

        .right::after {
            left: -16px;
        }

        .timeline-content {
            padding: 20px 30px;
            background-color: white;
            position: relative;
            border-radius: 10px;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.1);
            border-left: 5px solid #3498db;
        }

        .timeline-year {
            background: #3498db;
            color: white;
            padding: 5px 15px;
            border-radius: 15px;
            font-size: 0.9em;
            font-weight: bold;
            display: inline-block;
            margin-bottom: 10px;
        }

        .timeline-title {
            color: #2c3e50;
            font-size: 1.3em;
            font-weight: 600;
            margin-bottom: 10px;
        }

        .timeline-description {
            color: #7f8c8d;
            line-height: 1.6;
        }

        /* References */
        .references {
            background: white;
            padding: 30px;
            border-radius: 15px;
            margin: 30px 0;
        }

        .references h2 {
            color: #2c3e50;
            font-size: 2em;
            margin-bottom: 25px;
            text-align: center;
        }

        .reference-list {
            list-style: none;
            counter-reset: reference-counter;
        }

        .reference-list li {
            counter-increment: reference-counter;
            margin-bottom: 15px;
            padding-left: 30px;
            position: relative;
            line-height: 1.6;
            color: #2c3e50;
        }

        .reference-list li::before {
            content: counter(reference-counter);
            position: absolute;
            left: 0;
            top: 0;
            background: #3498db;
            color: white;
            width: 20px;
            height: 20px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 0.8em;
            font-weight: bold;
        }

        /* Notes Section */
        .notes {
            background: linear-gradient(135deg, #6c5ce7, #a29bfe);
            color: white;
            padding: 25px;
            border-radius: 15px;
            margin: 30px 0;
            box-shadow: 0 10px 20px rgba(108, 92, 231, 0.3);
        }

        .notes h3 {
            margin-bottom: 15px;
            font-size: 1.4em;
        }

        .notes ul {
            list-style: none;
            padding-left: 0;
        }

        .notes li {
            padding: 8px 0;
            padding-left: 25px;
            position: relative;
            line-height: 1.6;
        }

        .notes li::before {
            content: "✓";
            position: absolute;
            left: 0;
            color: #00b894;
            font-weight: bold;
            font-size: 1.2em;
        }

        @media (max-width: 768px) {
            .container {
                margin: 10px;
                border-radius: 15px;
            }
            
            .content {
                padding: 20px;
            }
            
            h1 {
                font-size: 2.2em;
            }
            
            .strength-container {
                grid-template-columns: 1fr;
            }
            
            .intro-grid {
                grid-template-columns: 1fr;
            }
            
            .timeline::after {
                left: 31px;
            }
            
            .timeline-item {
                width: 100%;
                padding-left: 70px;
                padding-right: 25px;
            }
            
            .timeline-item::before {
                left: 60px;
                border: medium solid white;
                border-width: 10px 10px 10px 0;
                border-color: transparent white transparent transparent;
            }
            
            .left::after, .right::after {
                left: 15px;
            }
            
            .right {
                left: 0%;
            }
           footer {
            background: #24292f;
            color: #f0f6fc;
            padding: 40px 0;
            text-align: center;
        }

        footer p {
            color: #8b949e;
            font-size: 0.875rem;
            margin-bottom: 8px;
        }

        footer a {
            color: #58a6ff;
            text-decoration: none;
        }

        footer a:hover {
            text-decoration: underline;
        }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Noradrenaline</h1>
            <p class="subtitle">Evidence-Based Clinical Guide | Updated January 2025</p>
            <div class="nav-buttons">
                <button class="nav-btn active" onclick="showTab('intro')">Introduction</button>
                <button class="nav-btn" onclick="showTab('dosage-tab')">Dosage Tables</button>
                <button class="nav-btn" onclick="showTab('calculations-tab')">Calculations</button>
                <button class="nav-btn" onclick="showTab('evidence')">Evidence</button>
                <button class="nav-btn" onclick="showTab('timeline')">Timeline</button>
                <button class="nav-btn" onclick="showTab('references')">References</button>
            </div>
        </header>

        <div class="content">
            <!-- Introduction Tab -->
            <div id="intro" class="tab-content active">
                <h2 style="text-align: center; color: #2c3e50; font-size: 2.5em; margin-bottom: 30px;">Introduction to Noradrenaline</h2>
                
                <div class="intro-grid">
                    <div class="intro-card">
                        <h3>🧬 Pharmacology</h3>
                        <p><strong>Noradrenaline (norepinephrine)</strong> is a potent endogenous catecholamine that functions as both a neurotransmitter and hormone. It acts primarily as an α1-adrenergic agonist with some β1-adrenergic activity.</p>
                        <ul>
                            <li><strong>Mechanism:</strong> Vasoconstriction via α1-receptors</li>
                            <li><strong>Effects:</strong> Increases SVR and MAP</li>
                            <li><strong>Half-life:</strong> 2-3 minutes</li>
                            <li><strong>Metabolism:</strong> MAO and COMT</li>
                        </ul>
                    </div>
                    
                    <div class="intro-card">
                        <h3>⚕️ Clinical Indications</h3>
                        <p>Noradrenaline is the <strong>first-line vasopressor</strong> recommended for septic shock by major guidelines including the Surviving Sepsis Campaign (2021).</p>
                        <ul>
                            <li>Septic shock (first-line)</li>
                            <li>Distributive shock</li>
                            <li>Post-operative hypotension</li>
                            <li>Cardiogenic shock (selected cases)</li>
                        </ul>
                    </div>
                </div>

                <div class="key-info">
                    <h3>🎯 Key Clinical Points</h3>
                    <p><strong>Standard Preparation:</strong> 4mg/2ml ampules • <strong>First-line choice</strong> over dopamine • <strong>Target MAP:</strong> ≥65 mmHg • <strong>Central line required</strong> for concentrations >4mg in 250ml</p>
                </div>

                <div class="intro-grid">
                    <div class="intro-card">
                        <h3>✅ Advantages</h3>
                        <ul>
                            <li>Lower arrhythmia risk vs dopamine</li>
                            <li>Predictable dose-response</li>
                            <li>Preserves renal blood flow</li>
                            <li>Extensive evidence base</li>
                            <li>Well-established safety profile</li>
                        </ul>
                    </div>
                    
                    <div class="intro-card">
                        <h3>⚠️ Considerations</h3>
                        <ul>
                            <li>Requires central venous access</li>
                            <li>Risk of tissue necrosis if extravasated</li>
                            <li>May reduce splanchnic blood flow</li>
                            <li>Contraindicated in uncorrected hypovolemia</li>
                            <li>Monitor for digital ischemia</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Dosage Tables Tab -->
            <div id="dosage-tab" class="tab-content">
                <h2 style="text-align: center; color: #2c3e50; font-size: 2.5em; margin-bottom: 20px;">Noradrenaline Dosage Reference Tables</h2>
                <p style="text-align: center; color: #7f8c8d; font-size: 1.2em; margin-bottom: 30px;">Quick Reference Guide for Syringe Pump Administration</p>

                <div class="key-info">
                    <h3>🚨 Key Information</h3>
                    <p><strong>Standard Ampule:</strong> 4mg/2ml (2mg/ml concentration)<br>
                    <strong>Diluent:</strong> D5W (Dextrose 5% in Water)<br>
                    <strong>Syringe Size:</strong> 50ml total volume<br>
                    <strong>Typical Starting Dose:</strong> 0.05-0.1 mcg/kg/min</p>
                </div>

                <div class="strength-container">
                    <!-- Single Strength -->
                    <div class="strength-card single">
                        <div class="strength-header">
                            SINGLE STRENGTH
                        </div>
                        <div class="preparation">
                            <h4>📋 Preparation</h4>
                            <p><strong>1 ampule (4mg)</strong> + D5W to 50ml<br>
                            <strong>Final Concentration:</strong> 80 mcg/ml</p>
                        </div>
                        <div class="formula-box">
                            mcg/min = ml/hr × 1.33
                        </div>
                        <table class="dosage-table">
                            <tr>
                                <th>ml/hr</th>
                                <th>mcg/min</th>
                                <th>mcg/kg/min<br>(70kg patient)</th>
                                <th>Clinical Use</th>
                            </tr>
                            <tr class="low-dose">
                                <td>1</td>
                                <td>1.3</td>
                                <td>0.02</td>
                                <td>Minimal support</td>
                            </tr>
                            <tr class="low-dose">
                                <td>2</td>
                                <td>2.7</td>
                                <td>0.04</td>
                                <td>Low dose</td>
                            </tr>
                            <tr class="low-dose">
                                <td>3</td>
                                <td>4.0</td>
                                <td>0.06</td>
                                <td>Maintenance</td>
                            </tr>
                            <tr class="low-dose">
                                <td>4</td>
                                <td>5.3</td>
                                <td>0.08</td>
                                <td>Standard dose</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>5</td>
                                <td>6.7</td>
                                <td>0.10</td>
                                <td>Moderate support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>7</td>
                                <td>9.3</td>
                                <td>0.13</td>
                                <td>Higher support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>10</td>
                                <td>13.3</td>
                                <td>0.19</td>
                                <td>Significant support</td>
                            </tr>
                            <tr class="high-dose">
                                <td>15</td>
                                <td>20.0</td>
                                <td>0.29</td>
                                <td>High dose</td>
                            </tr>
                        </table>
                    </div>

                    <!-- Double Strength -->
                    <div class="strength-card double">
                        <div class="strength-header">
                            DOUBLE STRENGTH
                        </div>
                        <div class="preparation">
                            <h4>📋 Preparation</h4>
                            <p><strong>2 ampules (8mg)</strong> + D5W to 50ml<br>
                            <strong>Final Concentration:</strong> 160 mcg/ml</p>
                        </div>
                        <div class="formula-box">
                            mcg/min = ml/hr × 2.67
                        </div>
                        <table class="dosage-table">
                            <tr>
                                <th>ml/hr</th>
                                <th>mcg/min</th>
                                <th>mcg/kg/min<br>(70kg patient)</th>
                                <th>Clinical Use</th>
                            </tr>
                            <tr class="low-dose">
                                <td>1</td>
                                <td>2.7</td>
                                <td>0.04</td>
                                <td>Low dose</td>
                            </tr>
                            <tr class="low-dose">
                                <td>2</td>
                                <td>5.3</td>
                                <td>0.08</td>
                                <td>Standard dose</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>3</td>
                                <td>8.0</td>
                                <td>0.11</td>
                                <td>Moderate support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>4</td>
                                <td>10.7</td>
                                <td>0.15</td>
                                <td>Good support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>5</td>
                                <td>13.3</td>
                                <td>0.19</td>
                                <td>Significant support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>6</td>
                                <td>16.0</td>
                                <td>0.23</td>
                                <td>High-moderate</td>
                            </tr>
                            <tr class="high-dose">
                                <td>8</td>
                                <td>21.3</td>
                                <td>0.30</td>
                                <td>High dose</td>
                            </tr>
                            <tr class="high-dose">
                                <td>10</td>
                                <td>26.7</td>
                                <td>0.38</td>
                                <td>Very high dose</td>
                            </tr>
                        </table>
                    </div>

                    <!-- Quadruple Strength -->
                    <div class="strength-card quadruple">
                        <div class="strength-header">
                            QUADRUPLE STRENGTH
                        </div>
                        <div class="preparation">
                            <h4>📋 Preparation</h4>
                            <p><strong>4 ampules (16mg)</strong> + D5W to 50ml<br>
                            <strong>Final Concentration:</strong> 320 mcg/ml</p>
                        </div>
                        <div class="formula-box">
                            mcg/min = ml/hr × 5.33
                        </div>
                        <table class="dosage-table">
                            <tr>
                                <th>ml/hr</th>
                                <th>mcg/min</th>
                                <th>mcg/kg/min<br>(70kg patient)</th>
                                <th>Clinical Use</th>
                            </tr>
                            <tr class="low-dose">
                                <td>1</td>
                                <td>5.3</td>
                                <td>0.08</td>
                                <td>Standard dose</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>2</td>
                                <td>10.7</td>
                                <td>0.15</td>
                                <td>Good support</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>3</td>
                                <td>16.0</td>
                                <td>0.23</td>
                                <td>High-moderate</td>
                            </tr>
                            <tr class="medium-dose">
                                <td>4</td>
                                <td>21.3</td>
                                <td>0.30</td>
                                <td>High dose</td>
                            </tr>
                            <tr class="high-dose">
                                <td>5</td>
                                <td>26.7</td>
                                <td>0.38</td>
                                <td>Very high dose</td>
                            </tr>
                            <tr class="high-dose">
                                <td>6</td>
                                <td>32.0</td>
                                <td>0.46</td>
                                <td>Maximum support</td>
                            </tr>
                            <tr class="high-dose">
                                <td>8</td>
                                <td>42.7</td>
                                <td>0.61</td>
                                <td>Crisis management</td>
                            </tr>
                            <tr class="high-dose">
                                <td>10</td>
                                <td>53.3</td>
                                <td>0.76</td>
                                <td>Extreme support</td>
                            </tr>
                        </table>
                    </div>
                </div>

                <div class="notes">
                    <h3>📝 Clinical Notes & Guidelines</h3>
                    <ul>
                        <li><strong>Starting Dose:</strong> Typically 0.05-0.1 mcg/kg/min (3.5-7 mcg/min for 70kg patient)</li>
                        <li><strong>Titration:</strong> Increase by 0.05-0.1 mcg/kg/min every 3-5 minutes based on response</li>
                        <li><strong>Maximum Dose:</strong> Generally avoid >1 mcg/kg/min; consider additional vasopressors</li>
                        <li><strong>Central Line:</strong> Mandatory for concentrations >80 mcg/ml due to extravasation risk</li>
                        <li><strong>Monitoring:</strong> Continuous BP, HR, urine output, and peripheral perfusion</li>
                        <li><strong>Weaning:</strong> Reduce gradually by 25-50% every 30-60 minutes as tolerated</li>
                        <li><strong>Compatibility:</strong> Compatible with D5W, normal saline; avoid alkaline solutions</li>
                        <li><strong>Stability:</strong> Use within 24 hours of preparation; protect from light</li>
                    </ul>
                </div>
            </div>

            <!-- Calculations Tab -->
            <div id="calculations-tab" class="tab-content">
                <h2 style="text-align: center; color: #2c3e50; font-size: 2.5em; margin-bottom: 20px;">🧮 Noradrenaline Dosage Calculations</h2>
                <p style="text-align: center; color: #7f8c8d; font-size: 1.2em; margin-bottom: 30px;">Complete Guide to Ampule Loading, Concentrations, and Dosage Conversions</p>

                <!-- Step 1: Understanding the Ampule -->
                <div class="step-container">
                    <div class="step-card">
                        <div class="step-header">
                            <div class="step-number">1</div>
                            <div class="step-title">Understanding the Ampule</div>
                        </div>
                        
                        <div style="background: #fff3cd; padding: 15px; border-radius: 8px; border-left: 4px solid #ffc107; margin: 15px 0;">
                            <strong>Standard Noradrenaline Ampule:</strong><br>
                            • Total content: 4mg of noradrenaline<br>
                            • Volume: 2ml<br>
                            • Concentration: 2mg/ml (or 2000 mcg/ml)
                        </div>

                        <div class="calculation-box">
                            <strong>Basic Ampule Calculation:</strong><br>
                            4mg ÷ 2ml = 2mg/ml<br>
                            Converting to micrograms: 2mg/ml × 1000 = 2000 mcg/ml
                        </div>

                        <div style="background: #d4edda; padding: 15px; border-radius: 8px; border-left: 4px solid #28a745; margin: 15px 0;">
                            <strong>Key Point:</strong> Each ampule contains 4000 mcg (4mg) of noradrenaline in 2ml volume.
                        </div>
                    </div>
                </div>

                <!-- Step 2: Dilution Calculation -->
                <div class="step-container">
                    <div class="step-card">
                        <div class="step-header">
                            <div class="step-number">2</div>
                            <div class="step-title">Dilution to 50ml Syringe</div>
                        </div>

                        <p>We dilute the ampule(s) with D5W to reach a total volume of 50ml in the syringe.</p>

                        <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 20px 0;">
                            <div style="background: white; padding: 20px; border-radius: 10px; box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1); border: 2px solid #e9ecef;">
                                <h4 style="color: #2c3e50; margin-bottom: 10px;">Single Strength (1 ampule)</h4>
                                <div class="calculation-box">
                                    Total drug: 4mg (4000 mcg)<br>
                                    Final volume: 50ml<br>
                                    <strong>Concentration = 4000 mcg ÷ 50ml = 80 mcg/ml</strong>
                                </div>
                            </div>

                            <div style="background: white; padding: 20px; border-radius: 10px; box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1); border: 2px solid #e9ecef;">
                                <h4 style="color: #2c3e50; margin-bottom: 10px;">Double Strength (2 ampules)</h4>
                                <div class="calculation-box">
                                    Total drug: 8mg (8000 mcg)<br>
                                    Final volume: 50ml<br>
                                    <strong>Concentration = 8000 mcg ÷ 50ml = 160 mcg/ml</strong>
                                </div>
                            </div>

                            <div style="background: white; padding: 20px; border-radius: 10px; box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1); border: 2px solid #e9ecef;">
                                <h4 style="color: #2c3e50; margin-bottom: 10px;">Quadruple Strength (4 ampules)</h4>
                                <div class="calculation-box">
                                    Total drug: 16mg (16000 mcg)<br>
                                    Final volume: 50ml<br>
                                    <strong>Concentration = 16000 mcg ÷ 50ml = 320 mcg/ml</strong>
                                </div>
                            </div>
                        </div>

                        <div class="formula-box">
                            FORMULA: Final Concentration (mcg/ml) = (Number of ampules × 4000 mcg) ÷ 50ml
                        </div>
                    </div>
                </div>

                <!-- Step 3: Converting ml/hr to mcg/min -->
                <div class="step-container">
                    <div class="step-card">
                        <div class="step-header">
                            <div class="step-number">3</div>
                            <div class="step-title">Converting ml/hr to mcg/min</div>
                        </div>

                        <p>To convert the infusion rate from ml/hr (what you set on the pump) to mcg/min (the clinical dose), we use this conversion:</p>

                        <div class="formula-box">
                            mcg/min = (ml/hr × concentration in mcg/ml) ÷ 60
                        </div>

                        <div style="background: linear-gradient(135deg, #6c5ce7, #a29bfe); color: white; padding: 30px; border-radius: 15px; margin: 30px 0;">
                            <h3 style="font-size: 1.8em; margin-bottom: 20px;">🔍 Detailed Example: Double Strength Solution</h3>
                            
                            <div style="background: rgba(255, 255, 255, 0.1); padding: 15px; border-radius: 8px; margin: 15px 0; border-left: 4px solid #00b894;">
                                <strong>Step 1:</strong> Prepare solution<br>
                                2 ampules (8mg) + D5W to 50ml = 160 mcg/ml concentration
                            </div>

                            <div style="background: rgba(255, 255, 255, 0.1); padding: 15px; border-radius: 8px; margin: 15px 0; border-left: 4px solid #00b894;">
                                <strong>Step 2:</strong> Set pump rate<br>
                                Let's say we want to infuse at 5 ml/hr
                            </div>

                            <div style="background: rgba(255, 255, 255, 0.1); padding: 15px; border-radius: 8px; margin: 15px 0; border-left: 4px solid #00b894;">
                                <strong>Step 3:</strong> Calculate mcg/min<br>
                                mcg/min = (5 ml/hr × 160 mcg/ml) ÷ 60<br>
                                mcg/min = 800 mcg/hr ÷ 60<br>
                                <strong>mcg/min = 13.3 mcg/min</strong>
                            </div>

                            <div style="background: rgba(255, 255, 255, 0.1); padding: 15px; border-radius: 8px; margin: 15px 0; border-left: 4px solid #00b894;">
                                <strong>Step 4:</strong> Calculate mcg/kg/min (for 70kg patient)<br>
                                mcg/kg/min = 13.3 mcg/min ÷ 70kg<br>
                                <strong>mcg/kg/min = 0.19 mcg/kg/min</strong>
                            </div>
                        </div>

                        <div style="background: #f8d7da; padding: 15px; border-radius: 8px; border-left: 4px solid #dc3545; margin: 15px 0;">
                            <strong>Remember:</strong> The pump rate (ml/hr) × concentration (mcg/ml) gives you mcg/hr. Divide by 60 to get mcg/min.
                        </div>
                    </div>
                </div>

                <!-- Step 4: Quick Conversion Factors -->
                <div class="step-container">
                    <div class="step-card">
                        <div class="step-header">
                            <div class="step-number">4</div>
                            <div class="step-title">Quick Conversion Factors</div>
                        </div>

                        <p>For rapid calculations, use these conversion factors:</p>

                        <table style="width: 100%; border-collapse: collapse; margin: 20px 0; background: white; border-radius: 10px; overflow: hidden; box-shadow: 0 5px 15px rgba(0, 0, 0, 0.1);">
                            <tr>
                                <th style="background: linear-gradient(135deg, #34495e, #2c3e50); color: white; padding: 15px; font-weight: bold; text-align: center;">Strength</th>
                                <th style="background: linear-gradient(135deg, #34495e, #2c3e50); color: white; padding: 15px; font-weight: bold; text-align: center;">Concentration</th>
                                <th style="background: linear-gradient(135deg, #34495e, #2c3e50); color: white; padding: 15px; font-weight: bold; text-align: center;">Conversion Factor</th>
                                <th style="background: linear-gradient(135deg, #34495e, #2c3e50); color: white; padding: 15px; font-weight: bold; text-align: center;">Quick Formula</th>
                            </tr>
                            <tr>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">Single (1 amp)</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">80 mcg/ml</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">1.33</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">mcg/min = ml/hr × 1.33</td>
                            </tr>
                            <tr style="background-color: #f8f9fa;">
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">Double (2 amps)</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">160 mcg/ml</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">2.67</td>
                                <td style="padding: 12px 15px; text-align: center; border-bottom: 1px solid #eee;">mcg/min = ml/hr × 2.67</td>
                            </tr>
                            <tr>
                                <td style="padding: 12px 15px; text-align: center;">Quadruple (4 amps)</td>
                                <td style="padding: 12px 15px; text-align: center;">320 mcg/ml</td>
                                <td style="padding: 12px 15px; text-align: center;">5.33</td>
                                <td style="padding: 12px 15px; text-align: center;">mcg/min = ml/hr × 5.33</td>
                            </tr>
                        </table>

                        <div style="background: #fff3cd; padding: 15px; border-radius: 8px; border-left: 4px solid #ffc107; margin: 15px 0;">
                            <strong>How we get these factors:</strong><br>
                            Conversion Factor = Concentration (mcg/ml) ÷ 60<br>
                            Example: 160 mcg/ml ÷ 60 = 2.67
                        </div>
                    </div>
                </div>
            </div>

            <!-- Evidence Tab -->
            <div id="evidence" class="tab-content">
                <div class="evidence-section">
                    <h2>🔬 Clinical Evidence for Noradrenaline</h2>
                    
                    <div class="trial-card">
                        <div class="trial-title">SOAP II Trial - Landmark Study Establishing Noradrenaline Superiority</div>
                        <div class="trial-year">2010</div>
                        <p><strong>Study:</strong> Comparison of Dopamine and Norepinephrine in the Treatment of Shock (De Backer et al., 2010)</p>
                        <p><strong>Design:</strong> Multicenter, randomized, double-blind trial (n=1,679)</p>
                        <p><strong>Key Findings:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li>No significant difference in 28-day mortality (52.5% vs 48.5%, p=0.10)</li>
                            <li><strong>Significantly lower arrhythmia rate</strong> with noradrenaline (12.4% vs 24.1%, p<0.001)</li>
                            <li>Dopamine associated with increased mortality in cardiogenic shock subgroup</li>
                            <li>Established noradrenaline as preferred first-line vasopressor</li>
                        </ul>
                    </div>

                    <div class="trial-card">
                        <div class="trial-title">VASST Trial - Vasopressin vs Noradrenaline</div>
                        <div class="trial-year">2008</div>
                        <p><strong>Study:</strong> Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock (Russell et al., 2008)</p>
                        <p><strong>Design:</strong> Multicenter, randomized, double-blind trial (n=778)</p>
                        <p><strong>Key Findings:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li>No difference in 28-day mortality (35.4% vs 39.3%, p=0.26)</li>
                            <li>Vasopressin effective as noradrenaline-sparing agent</li>
                            <li>Trend toward benefit in less severe septic shock</li>
                            <li>Similar safety profile between agents</li>
                        </ul>
                    </div>

                    <div class="trial-card">
                        <div class="trial-title">Early Noradrenaline Administration - 2024-2025 Evidence</div>
                        <div class="trial-year">2024-2025</div>
                        <p><strong>Recent Meta-Analysis:</strong> Early norepinephrine for patients with septic shock (Shi et al., 2025)</p>
                        <p><strong>Key Findings:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li><strong>Early administration (≤1 hour)</strong> associated with lower 28-day mortality</li>
                            <li>Faster achievement of MAP ≥65 mmHg</li>
                            <li>Lower 24-hour fluid volumes required</li>
                            <li>Higher lactate clearance rates</li>
                        </ul>
                        <p><strong>Additional 2024 Studies:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li>Li et al. (2025): Noradrenaline initiation ≤1h reduces mortality</li>
                            <li>VASOSHOCK trial (ongoing): Early noradrenaline vs fluid therapy</li>
                        </ul>
                    </div>

                    <div class="trial-card">
                        <div class="trial-title">Surviving Sepsis Campaign Guidelines Evolution</div>
                        <div class="trial-year">2004-2021</div>
                        <p><strong>Guideline Progression:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li><strong>2004:</strong> First formal sepsis guidelines published</li>
                            <li><strong>2008:</strong> Dopamine and noradrenaline both recommended as first-line</li>
                            <li><strong>2012:</strong> Post-SOAP II shift toward noradrenaline preference</li>
                            <li><strong>2016:</strong> Noradrenaline established as first-line vasopressor</li>
                            <li><strong>2021:</strong> Continued noradrenaline recommendation with emphasis on early initiation</li>
                        </ul>
                    </div>

                    <div class="trial-card">
                        <div class="trial-title">Dosing Evidence Base</div>
                        <div class="trial-year">Multiple Studies</div>
                        <p><strong>Starting Dose Recommendations:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li><strong>Typical range:</strong> 0.05-0.1 mcg/kg/min (SSC 2021)</li>
                            <li><strong>Maximum dose:</strong> Generally <1 mcg/kg/min before adding second agent</li>
                            <li><strong>Titration:</strong> 0.05-0.1 mcg/kg/min increments every 3-5 minutes</li>
                        </ul>
                        <p><strong>Concentration Evidence:</strong></p>
                        <ul style="margin-left: 20px; color: #7f8c8d;">
                            <li>Standard 4mg/250ml (16 mcg/ml) most common</li>
                            <li>Higher concentrations (80-320 mcg/ml) for syringe pumps</li>
                            <li>Central line mandatory for concentrated solutions</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Timeline Tab -->
            <div id="timeline" class="tab-content">
                <h2 style="text-align: center; color: #2c3e50; font-size: 2.5em; margin-bottom: 30px;">⏱️ Evolution of Noradrenaline in Critical Care</h2>
                
                <div class="timeline">
                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">1946</div>
                            <div class="timeline-title">Discovery of Noradrenaline</div>
                            <div class="timeline-description">Ulf von Euler discovers noradrenaline as a neurotransmitter, laying the foundation for understanding its physiological role.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">1970s</div>
                            <div class="timeline-title">Early Clinical Use</div>
                            <div class="timeline-description">First clinical applications of noradrenaline in shock states. Initial concerns about organ perfusion limit widespread adoption.</div>
                        </div>
                    </div>

                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">1991</div>
                            <div class="timeline-title">First Sepsis Consensus</div>
                            <div class="timeline-description">Initial consensus definitions of sepsis published. Dopamine favored over noradrenaline due to perceived renal benefits.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">2001</div>
                            <div class="timeline-title">Early Goal-Directed Therapy</div>
                            <div class="timeline-description">Rivers et al. publish landmark EGDT trial, emphasizing early aggressive resuscitation including vasopressor use.</div>
                        </div>
                    </div>

                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">2004</div>
                            <div class="timeline-title">First Surviving Sepsis Campaign</div>
                            <div class="timeline-description">Initial evidence-based guidelines for sepsis management published. Dopamine and noradrenaline both recommended as first-line vasopressors.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">2008</div>
                            <div class="timeline-title">VASST Trial</div>
                            <div class="timeline-description">Major trial comparing vasopressin vs noradrenaline shows equivalence, establishing noradrenaline as safe and effective.</div>
                        </div>
                    </div>

                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">2010</div>
                            <div class="timeline-title">SOAP II - Game Changer</div>
                            <div class="timeline-description">Landmark trial demonstrates noradrenaline's superiority over dopamine with significantly lower arrhythmia rates, reshaping clinical practice.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">2012</div>
                            <div class="timeline-title">SSC Guidelines Update</div>
                            <div class="timeline-description">Post-SOAP II guidelines begin to favor noradrenaline over dopamine based on safety profile and clinical outcomes.</div>
                        </div>
                    </div>

                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">2016</div>
                            <div class="timeline-title">Noradrenaline First-Line</div>
                            <div class="timeline-description">SSC guidelines formally establish noradrenaline as the preferred first-line vasopressor for septic shock.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">2021</div>
                            <div class="timeline-title">Modern Guidelines</div>
                            <div class="timeline-description">Latest SSC guidelines reinforce noradrenaline preference and emphasize early initiation and goal-directed therapy.</div>
                        </div>
                    </div>

                    <div class="timeline-item left">
                        <div class="timeline-content">
                            <div class="timeline-year">2024-2025</div>
                            <div class="timeline-title">Early Administration Focus</div>
                            <div class="timeline-description">Latest research emphasizes timing: early noradrenaline (≤1 hour) associated with improved outcomes and reduced mortality.</div>
                        </div>
                    </div>

                    <div class="timeline-item right">
                        <div class="timeline-content">
                            <div class="timeline-year">Ongoing</div>
                            <div class="timeline-title">Future Directions</div>
                            <div class="timeline-description">VASOSHOCK trial and other studies investigating optimal timing, dosing strategies, and combination therapies continue to refine best practices.</div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- References Tab -->
            <div id="references" class="tab-content">
                <div class="references">
                    <h2>📚 References</h2>
                    <ol class="reference-list">
                        <li>De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., ... & Vincent, J. L. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. <em>New England Journal of Medicine</em>, 362(9), 779-789.</li>

                        <li>Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., ... & Ayers, D. (2008). Vasopressin versus norepinephrine infusion in patients with septic shock. <em>New England Journal of Medicine</em>, 358(9), 877-887.</li>

                        <li>Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., ... & Levy, M. (2021). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. <em>Intensive Care Medicine</em>, 47(11), 1181-1247.</li>

                        <li>Shi, R., Braïk, R., Monnet, X., Teboul, J. L., & Hamzaoui, O. (2025). Early norepinephrine for patients with septic shock: an updated systematic review and meta-analysis with trial sequential analysis. <em>Critical Care</em>, 29(1), 182.</li>

                        <li>Li, Y., Zhang, D., Li, H., Wang, Y., & Zhang, D. (2025). Effect of timing of norepinephrine administration on prognosis of patients with septic shock: a prospective cohort study. <em>Journal of Intensive Medicine</em>, 5(2), 160-166.</li>

                        <li>Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., ... & Dellinger, R. P. (2017). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. <em>Intensive Care Medicine</em>, 43(3), 304-377.</li>

                        <li>Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., ... & Moreno, R. (2013). Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. <em>Intensive Care Medicine</em>, 39(2), 165-228.</li>

                        <li>Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A. (2015). Vasopressors for the treatment of septic shock: systematic review and meta-analysis. <em>PLoS One</em>, 10(8), e0129305.</li>

                        <li>Garegrat, R., Patnaik, S., Suryawanshi, S., Chetan, C., Banait, N., Singh, P., ... & Suryawanshi, P. (2024). A pilot randomized controlled trial comparing noradrenaline and adrenaline as a first-line vasopressor for fluid-refractory septic shock in neonates. <em>Frontiers in Pediatrics</em>, 12, 1443990.</li>

                        <li>Morales, S., Wendel-Garcia, P. D., Ibarra-Estrada, M., García-Salcido, R., Aguirre-Avalos, G., Escobar-Ortiz, L., ... & Teboul, J. L. (2024). The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients. <em>Critical Care</em>, 28(1), 216.</li>

                        <li>Ahn, C., Yu, G., Shin, T. G., Cho, Y., Park, S., & Suh, G. Y. (2024). Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis. <em>Chest</em>, S0012-3692(24), 04581-91.</li>

                        <li>Vincent, J. L., De Backer, D., Wiedermann, C. J., Fukushima, S., Yamakawa, K., Antonelli, M., ... & Landoni, G. (2024). Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II. <em>Critical Care</em>, 28(1), 371.</li>

                        <li>Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., ... & Angus, D. C. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). <em>JAMA</em>, 315(8), 801-810.</li>

                        <li>Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., ... & Ramsay, G. (2003). 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. <em>Critical Care Medicine</em>, 31(4), 1250-1256.</li>

                        <li>Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., ... & Tomlanovich, M. (2001). Early goal-directed therapy in the treatment of severe sepsis and septic shock. <em>New England Journal of Medicine</em>, 345(19), 1368-1377.</li>

                        <li>Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., ... & Brett, S. J. (2016). Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. <em>JAMA</em>, 316(5), 509-518.</li>

                        <li>Ospina-Tascón, G. A., Hernandez, G., Alvarez, I., Calderón-Tapia, L. E., Manzano-Nunez, R., Sánchez-Ortiz, A. I., ... & García, A. F. (2020). Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. <em>Critical Care</em>, 24(1), 52.</li>

                        <li>Kallimath, A., Garegrat, R., Patnaik, S., Singh, Y., Soni, N. B., & Suryawanshi, P. (2024). Hemodynamic effects of noradrenaline in neonatal septic shock: a prospective cohort study. <em>Journal of Tropical Pediatrics</em>, 70(2), fmae001.</li>

                        <li>Dünser, M. W., & Hasibeder, W. R. (2009). Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. <em>Journal of Intensive Care Medicine</em>, 24(5), 293-316.</li>

                        <li>Hamzaoui, O., Georger, J. F., Monnet, X., Ksouri, H., Maizel, J., Richard, C., & Teboul, J. L. (2010). Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. <em>Critical Care</em>, 14(4), R142.</li>
                    </ol>
                </div>
            </div>
        </div>
    </div>
<footer>
        <div class="container">
            <p>&copy; 2025 CCM Notes | ❤️ FOAMed </p>

            <p style="margin-top: 16px; font-size: 0.75rem;">
                <strong>Medical Disclaimer:</strong> This content is for educational purposes only and should not replace clinical judgment or institutional protocols.
            </p>
        </div>
    </footer>
    <script>
        function showTab(tabName) {
            // Hide all tab contents
            const tabContents = document.querySelectorAll('.tab-content');
            tabContents.forEach(tab => tab.classList.remove('active'));
            
            // Remove active class from all buttons
            const navBtns = document.querySelectorAll('.nav-btn');
            navBtns.forEach(btn => btn.classList.remove('active'));
            
            // Show selected tab
            document.getElementById(tabName).classList.add('active');
            
            // Add active class to clicked button
            event.target.classList.add('active');
        }
    </script>
</body>
</html>
